These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34232158)

  • 41. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study.
    de Goeij MC; Voormolen N; Halbesma N; de Jager DJ; Boeschoten EW; Sijpkens YW; Dekker FW; Grootendorst DC;
    BMC Nephrol; 2011 Aug; 12():38. PubMed ID: 21835038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents.
    Liu X; Steinman MA; Lee SJ; Peralta CA; Graham LA; Li Y; Jing B; Fung KZ; Odden MC
    J Am Geriatr Soc; 2023 Jul; 71(7):2131-2140. PubMed ID: 36826917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease.
    Weiner DE; Tighiouart H; Levey AS; Elsayed E; Griffith JL; Salem DN; Sarnak MJ
    J Am Soc Nephrol; 2007 Mar; 18(3):960-6. PubMed ID: 17301190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation.
    Pagonas N; Bauer F; Seibert FS; Seidel M; Schenker P; Kykalos S; Dürr M; Reinke P; Babel N; Viebahn R; Westhoff TH
    Sci Rep; 2019 Jul; 9(1):10507. PubMed ID: 31324868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.
    Konta T; Ikeda A; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Yoshida H; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
    Am J Hypertens; 2012 Mar; 25(3):342-7. PubMed ID: 22089103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey.
    Zheng Y; Tang L; Zhang W; Zhao D; Zhang D; Zhang L; Cai G; Chen X;
    Nephrol Dial Transplant; 2020 Jan; 35(1):155-161. PubMed ID: 30304540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
    Ali W; Gao G; Bakris GL
    Am J Nephrol; 2020; 51(3):249-254. PubMed ID: 31982868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Chiang HP; Chiu YW; Lee JJ; Hung CC; Hwang SJ; Chen HC
    Kidney Int; 2020 Feb; 97(2):402-413. PubMed ID: 31882172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Optimal Blood Pressure Target in Different Dialysis Populations.
    Jhee JH; Park J; Kim H; Kee YK; Park JT; Han SH; Yang CW; Kim NH; Kim YS; Kang SW; Kim YL; Yoo TH
    Sci Rep; 2018 Sep; 8(1):14123. PubMed ID: 30237432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
    Omae K; Ogawa T; Nitta K
    Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4-5.
    Chávez-Iñiguez JS; Zaragoza JJ; Camacho-Guerrero JR; Villavicencio-Cerón V; Valdez-Ortiz R; Huerta-Orozco AE; Chávez-Alonso G; Oliva-Martinez AE; Díaz-Villavicencio B; Calderón-García CE; González-Barajas JD; Arizaga-Nápoles M; De La Vega-Méndez FM; Gómez-Fregoso JA; Rodríguez-García FG; Navarro-Blackaller G; Medina-González R; Alcantar-Vallin L; García-García G
    Kidney Blood Press Res; 2023; 48(1):556-567. PubMed ID: 37544290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis.
    Wang C; Ye Y; Liu C; Zhou Y; Lv L; Cheng C; Li S; Lou T; Liu X
    Intern Med J; 2017 Aug; 47(8):900-906. PubMed ID: 28544243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of the blood pressure classification in the new 2017 ACC/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease.
    Maeda T; Yoshimura C; Takahashi K; Ito K; Yasuno T; Abe Y; Masutani K; Nakashima H; Mukoubara S; Arima H
    J Hum Hypertens; 2019 Dec; 33(12):873-878. PubMed ID: 31113986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Chang TI; Kim YH; Chung W; Yoo TH; Kang SW; Park SK; Chae DW; Oh KH; Han SH
    Nephrol Dial Transplant; 2022 Aug; 37(9):1722-1730. PubMed ID: 34473286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.
    Wang Q; Wang Y; Wang J; Zhang L; Zhao MH;
    J Am Heart Assoc; 2020 Jun; 9(12):e015359. PubMed ID: 32508195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.